InsidersTradesSigma
Track the SenzaGen AB share price and the full insider trade history of the company, a listed issuer based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, SenzaGen AB has logged 2 reports. Market capitalisation: €173.6m. The latest transaction was filed on 21 August 2025 (Purchase). Among the most active insiders: Bengt Peter Nählstedt. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€22,060
2 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Fundamental score
Ranked 24,499 of 29,064 companies
27.3
score / 100
Value19
Quality36
FCF yld-7.1%
Earn yld-6.7%
EV/EBITDA·
ROE-13%
Gross mgn65%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2025
Declarations2 total
250,000 shares@ €0.06790.0097% mcap100.0% of flowTeckningsoptionFI:A003R608-1
10,000 shares@ €0.50770.0029% mcap100.0% of flowAktieISIN SE0010219626FI:A003P059-1
2 of 2 declarations
关于 SenzaGen AB
SenzaGen AB是一家专注于开发化学品和药品安全测试的公司。它专注于创新解决方案，以评估物质对人类健康的影响。